WebMay 3, 2024 · Schinecker said the tests are an important step in determining whether someone may have immunity, but acknowledged that more research is required to … WebDr. Thomas Schinecker (1975) Dr. Alan Hippe (1967) Cristina A. Wilbur (1967) Position Chief Executive Officer Roche Group CEO Roche Pharmaceuticals CEO Roche Diagnostics Chief Financial & Information Officer Chief People Officer Enlarged Corporate Executive Committee Clear filter Name (year of birth) Dr. Aviv Regev (1971)
Roche Annual General Meeting 2024 - Yahoo Finance
WebDr. Thomas Schinecker serves as Chairman of the Board at Genentech, Inc. since March 2024. He serves as Chief Executive Officer at Roche Holding AG since March 15, 2024. ... Thomas Schinecker: Chief Executive Officer: less than a year: CHF5.34m: 0.00034% CHF 752.1k: Alan Hippe: Chief Financial & Information Officer: 12yrs: CHF6.05m: WebOct 18, 2024 · Roche’s New CEO Thomas Schinecker. Thomas Schinecker is set to replace long-standing CEO, Severin Schwan, in the leadership shakeup Roche … イルルカ 限界突破
Thomas Schinecker - Medtech Alert - PharmTech Focus
WebMar 14, 2024 · Today, Thomas Schinecker will assume my role as CEO of the Roche Group. I look forward to our future cooperation." The shareholders also approved an increase in the dividend for the past... WebAs recently published in the International Journal of Cancer, the IMPACT (IMproving Primary screening And Colposcopy Triage) trial demonstrated that Roche's CINtec PLUS Cytology, when used as a triage test for high-risk HPV, showed a significantly higher sensitivity in detecting cervical pre-cancers in HPV-positive women compared to Pap cytology. WebJul 22, 2024 · Schinecker most recently served at Roche as its chief of the diagnostics division, and during his 20-year career at the company, he held various international roles, serving as head of marketing and sales, and general manager in regional offices. He was then later appointed as Roche Diagnostics’ CEO in 2024. pacifica combat zone